Acuson and DHS close purchasing deal

Article

Imaging services firm Diagnostic Health Services and ultrasoundvendor Acuson have reached an agreement in which DHS will purchasenew Acuson scanners and upgrades worth $2.3 million. Dallas-basedDHS is the largest independent diagnostic provider client

Imaging services firm Diagnostic Health Services and ultrasoundvendor Acuson have reached an agreement in which DHS will purchasenew Acuson scanners and upgrades worth $2.3 million. Dallas-basedDHS is the largest independent diagnostic provider client forMountain View, CA-based Acuson, with over 50 systems in operation.

In other DHS news, the company said last month that it hascompleted the acquisition of cardiovascular ultrasound imagingprovider Advanced Diagnostic Imaging. The purchase, accomplishedthrough a stock swap, gives DHS increased presence in north Texas,according to DHS chairman and CEO Max Batzer.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.